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Canada
Preoperative (angiographic) and intraoperative assessment of vessel quality are compared.
Grafting of small diseased vessels provides complete revascularization in men and women.
Women are no more likely than men to have vessels less than 1.5 mm and are less likely to
have distal disease. Poor vessel quality increases operative risk but does not decrease long-term
survival.
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959 Gender-related differences in morbidity and mortality during combined
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Gender-related differences in morbidity and mortality are not well understood for combined
valve and coronary artery bypass grafting (V/CABG) surgery. We reviewed the results of
combined V/CABG at the Toronto General Hospital between January 1990 and October 2000.
Female gender was found to be an independent risk factor for combined morbidity and
mortality. As with isolated CABG, women undergoing combined procedures had more
premorbid conditions, were more often in heart failure, had an equal incidence of triple vessel
disease but received fewer grafts than men, and, therefore, were more frequently incompletely
revascularized.
965 Risk factors for atherosclerosis and the degeneration of pericardial valves
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Munich, Germany
Recent studies have suggested an atherosclerotic cause of aortic stenosis. We hypothesized that
risk factors for atherosclerosis might also be involved in the degeneration of pericardial heart
valves and lead to reoperation as a result of structural valve failure, especially in younger
patients with high degeneration rates. In 1984 and 1985, 161 patients received Hancock
extracorporeal pericardial aortic valves at age 54  11 years. Reoperations were associated
with smoking, diabetes mellitus, female sex, and cholesterol and triglyceride levels in patients
younger than 57 years of age. Lowering of triglyceride and cholesterol levels, smoking
cessation, and patient selection might be new concepts to avoid degeneration of bioprostheses
in younger patients.
969 Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and
explantation f
Robert Saeid Farivar, MD, PhD, and Lawrence H. Cohn, MD, Boston, Mass
A retrospective cohort analysis was used to determine whether cholesterol levels might be
linked to bioprosthetic valvular calcification. Case-control analysis documented that patients
with explanted tissue valves had higher mean serum cholesterol levels than matched valve
recipients who had equivalent survivals. The odds ratio for valve explantation was 3.9 times
that for patients with cholesterol levels of greater than 200 mg/dL.
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